Type I diabetes is a major risk factor for vascular complications including peripheral and coronary artery disease, cerebrovascular disease, impaired wound healing, and neuropathy. The extent of ischemic damage resulting from these complications is greatly increased by a diabetes-induced impairment in compensatory new blood vessel growth (neovascularization). Preliminary data suggest that recruitment, proliferation and assembly of bone marrow-derived endothelial progenitor cells (EPCs) into new vessels (vasculogenesis) are impaired in diabetes by multiple defects in both EPC function and trafficking. It is our central hypothesis that hypoxia is a fundamental mediator of vasculogenesis and that diabetes, by blunting the hypoxic response, leads to dysfunction in progenitor cell function, trafficking, and ischemia-induced signaling. This collaborative research project will combine the resources of a vascular biology laboratory having expertise in endothelial progenitor cell (EPC) mediated vasculogenesis (PI-Gurtner) with a biochemistry laboratory recognized for its accomplishments in delineating the cellular and molecular mechanisms of diabetic complications (PI-Brownlee). Dr. Gurtner will investigate the multiple alterations in the vasculogenic cascade induced by diabetes and Dr. Brownlee will investigate the mechanisms by which these disparate alterations are induced by hyperglycemia induced reactive oxygen species (ROS) overproduction, focusing on impairments in HIF-1alpha mediated gene transactivation. In SA 1, we will define the role hypoxia plays in mediating stem/progenitor cell function in the bone marrow niche under normal conditions. In SA 2, we will determine the impact diabetes has on progenitor cell function within this hypoxemic niche. In SA 3, we will investigate the mechanism by which diabetes affects hypoxic signaling and vasculogenesis in injured tissue. Finally, SA 4 will investigate the effects of hyperglycemia-induced ROS on HIF-1alpha stability and HIF-1alpha-mediated gene transcription during the hypoxia response. Results from the proposed studies carried out with the combined and complementary expertise of our two groups will allow for the rational development of novel strategies to restore normal compensatory vasculogenesis in diabetes, thus preventing the poor outcome of cardiovascular events (Ml, stroke, amputation) associated with the disease
| Bonham, Clark A; Rodrigues, Melanie; Galvez, Michael et al. (2018) Deferoxamine can prevent pressure ulcers and accelerate healing in aged mice. Wound Repair Regen 26:300-305 |
| Rodrigues, Melanie; Gurtner, Geoffrey (2017) Black, White, and Gray: Macrophages in Skin Repair and Disease. Curr Pathobiol Rep 5:333-342 |
| Duscher, Dominik; Januszyk, Michael; Maan, Zeshaan N et al. (2017) Comparison of the Hydroxylase Inhibitor Dimethyloxalylglycine and the Iron Chelator Deferoxamine in Diabetic and Aged Wound Healing. Plast Reconstr Surg 139:695e-706e |
| Rodrigues, Melanie; Wong, Victor W; Gurtner, Geoffrey C (2016) Finding a needle in a ""needlestack"". Cell Cycle 15:3331-3332 |
| Duscher, Dominik; Luan, Anna; Rennert, Robert C et al. (2016) Suction assisted liposuction does not impair the regenerative potential of adipose derived stem cells. J Transl Med 14:126 |
| Shah, Manasi S; Brownlee, Michael (2016) Molecular and Cellular Mechanisms of Cardiovascular Disorders in Diabetes. Circ Res 118:1808-29 |
| Whittam, Alexander J; Maan, Zeshaan N; Duscher, Dominik et al. (2016) Challenges and Opportunities in Drug Delivery for Wound Healing. Adv Wound Care (New Rochelle) 5:79-88 |
| Duscher, Dominik; Atashroo, David; Maan, Zeshaan N et al. (2016) Ultrasound-Assisted Liposuction Does Not Compromise the Regenerative Potential of Adipose-Derived Stem Cells. Stem Cells Transl Med 5:248-57 |
| Jung, Kenneth; Covington, Scott; Sen, Chandan K et al. (2016) Rapid identification of slow healing wounds. Wound Repair Regen 24:181-8 |
| Kosaraju, Revanth; Rennert, Robert C; Maan, Zeshaan N et al. (2016) Adipose-Derived Stem Cell-Seeded Hydrogels Increase Endogenous Progenitor Cell Recruitment and Neovascularization in Wounds. Tissue Eng Part A 22:295-305 |
Showing the most recent 10 out of 44 publications
